Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach.

Autor: van den Broek MP, Groenendaal F, Toet MC, van Straaten HL, van Hasselt JG, Huitema AD, de Vries LS, Egberts AC, Rademaker CM, van den Broek, M P H, Groenendaal, F, Toet, M C, van Straaten, H L M, van Hasselt, J G C, Huitema, A D R, de Vries, L S, Egberts, A C G, Rademaker, C M A

Publikováno v: Clinical Pharmacokinetics; 2012, Vol. 51 Issue 10, p671-679, 9p

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis

Autor: Heijstek MW, Wulffraat NM, Eken Y, Pluijm SMF, Rademaker CMA, de Jonge R

Publikováno v: Pediatric Rheumatology Online Journal, Vol 6, Iss Suppl 1, p P15 (2008)

Externí odkaz: https://doaj.org/article/45c80ce798d64259a3ac59de110d2e2c

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force.

Autor: Southall NT; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA. southalln@mail.nih.gov., Natarajan M; Rare Diseases Drug Discovery Unit, Takeda, Cambridge, MA, USA., Lau LPL; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.; IRDiRC Scientific Secretariat, Inserm-US14, Paris, France., Jonker AH; IRDiRC Scientific Secretariat, Inserm-US14, Paris, France., Deprez B; Université de Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, Lille, France.; Apteeus, Campus Institut Pasteur de Lille, Lille, France., Guilliams T; HealX, Cambridge, UK., Hunter L; University of Colorado, Denver School of Medicine, Denver, USA., Rademaker CM; University Medical Center Utrecht, Utrecht, the Netherlands., Hivert V; EURORDIS-Rare Diseases Europe, Paris, France., Ardigò D; Chiesi Farmaceutici SpA, Parma, Italy.

Publikováno v: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2019 Oct 15; Vol. 14 (1), pp. 225. Date of Electronic Publication: 2019 Oct 15.

Paediatric Drug Development and Formulation Design-a European Perspective.

Autor: Van Riet-Nales DA; Medicines Evaluation Board in the Netherlands, Quality department, Team I (chemical pharmaceutical assessments), P.O. Box 8275, 3503 RG, Utrecht, The Netherlands. da.v.riet@cbg-meb.nl.; Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. da.v.riet@cbg-meb.nl., Kozarewicz P; European Medicines Agency, Evaluation Procedures B Service in Procedure Management Department, London, UK., Aylward B; Health Products Regulatory Authority, Dublin, Ireland., de Vries R; Medicines Evaluation Board in the Netherlands, Quality department, Team I (chemical pharmaceutical assessments), P.O. Box 8275, 3503 RG, Utrecht, The Netherlands., Egberts TC; Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Rademaker CM; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., Schobben AF; Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.

Publikováno v: AAPS PharmSciTech [AAPS PharmSciTech] 2017 Feb; Vol. 18 (2), pp. 241-249. Date of Electronic Publication: 2016 Jun 07.

Methods of administering oral formulations and child acceptability.

Autor: van Riet-Nales DA; Medicines Evaluation Board in the Netherlands, Department of Chemical Pharmaceutical Assessments, Utrecht, The Netherlands(1); Utrecht University, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, The Netherlands. Electronic address: da.v.riet@cbg-meb.nl., Ferreira JA; National Institute for Public Health and the Environment, Department of Statistics, Modelling and Data Management (SMG), Bilthoven, The Netherlands., Schobben AF; Medicines Evaluation Board in the Netherlands, Department of Chemical Pharmaceutical Assessments, Utrecht, The Netherlands(1); Utrecht University, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, The Netherlands., de Neef BJ; Stichting Thuiszorg en Maatschappelijk Werk Rivierenland, Section Child Care, Tiel, The Netherlands., Egberts TC; Utrecht University, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, The Netherlands; University Medical Centre Utrecht, Department of Clinical Pharmacy, Utrecht, The Netherlands., Rademaker CM; University Medical Centre Utrecht, Department of Clinical Pharmacy, Utrecht, The Netherlands.

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2015 Aug 01; Vol. 491 (1-2), pp. 261-7. Date of Electronic Publication: 2015 Jul 02.